Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-126654
Filing Date
2025-12-30
Accepted
2025-12-30 16:30:01
Documents
2
Period of Report
2025-12-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0271224-6k_anbio.htm 6-K 9047
2 PRESS RELEASE - ANBIO BIOTECHNOLOGY ANNOUNCED UNAUDITED FINANCIAL RESULTS FOR TH ea027122401ex99-1_anbio.htm EX-99.1 43560
  Complete submission text file 0001213900-25-126654.txt   53660
Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308
Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281
Anbio Biotechnology (Filer) CIK: 0001982708 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42526 | Film No.: 251614654
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)